Neogen Corporation Deferred Tax Liabilities, Leasing Arrangements
Neogen Corporation (NEOG) had Deferred Tax Liabilities, Leasing Arrangements of $4.10 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2026-07-30
- 2026-05-31: Deferred Tax Liabilities, Leasing Arrangements $4.10M.
- 2025-05-31: Deferred Tax Liabilities, Leasing Arrangements $4.30M; Deferred Tax Liabilities, Leasing Arrangements as first filed $4.31M.
- 2024-05-31: Deferred Tax Liabilities, Leasing Arrangements $3.67M.
- 2023-05-31: Deferred Tax Liabilities, Leasing Arrangements $1.83M.
| Period end | Deferred Tax Liabilities, Leasing Arrangements | Deferred Tax Liabilities, Leasing Arrangements as first filed |
|---|---|---|
| 2026-05-31 | $4.10M 10-K · filed 2026-07-30 | |
| 2025-05-31 | $4.30M 10-K · filed 2026-07-30 | $4.31M 10-K · filed 2025-07-30 |
| 2024-05-31 | $3.67M 10-K · filed 2025-07-30 | |
| 2023-05-31 | $1.83M 10-K · filed 2024-07-30 | |
| 2022-05-31 | $344.00K 10-K · filed 2023-08-15 | |
| 2021-05-31 | $213.00K 10-K · filed 2022-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |